Translational Science

We speak with an advocate for alternative drug testing methods about the challenges that lie ahead.

FDA to phase out mandatory animal testing with human-relevant methods for drug development

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Contribute to our special feature celebrating the future of pharma.

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path